To determine if these patient-derived cells were more similar to aggressive or non-aggressive ovarian cancer cell lines, we quantified NCEH1 activity in a co-culture system of CD45+ lymphocyte monocyte immune cells and aggressive SKOV3 or non-aggressive OVCAR3 cancer cells. The gene discussed is PTPRC; the disease is ovarian carcinoma.